Financial Statements
Directors’ approval Certificate by the company secretary Report of the independent auditors Directors’ report Directors’ remuneration report Balance sheets Income statements Cash flow statements Notes to the cash flow statements Statement of changes in shareholders’ equity Notes to the annual financial statements Annexure A Annexure B Annexure C Annexure D

Annexure D

Interest in joint ventures

			Percentage holding		Carrying value
Company	Country of incorporation	Nature of business	2006 %	2005 %	2006 Rm	2005 Rm	Year-end other than 30 September
National Renal are (Proprietary) Limited	South Africa	Providers of acute and chronic renal care	50,0	50,0	0,2	0,5
Olivedale Clinic Oncology Centre (Proprietary) Limited	South Africa	Providers of radiation therapy treatments	50,0	50,0	(1,1)	(0,1)
Parklands Stereotactic Radiosurgery (Proprietary) Limited	South Africa	Providers of stereotactic radiosurgery	50,0	50,0	(1,4)	(1,1)
Rand Clinic Oncology Centre (Proprietary) Limited	South Africa	Providers of radiation therapy treatments	50,0	50,0	(9,2)	(9,0)
The Ampath Holdings Trust	South Africa	Administration and logistical services to high technology pathology laboratories	50,0	50,0	(1,8)	17,7	28 February
Other	South Africa	Various			1,6	3,7
Total interest in joint ventures					(11,7)	11,7
Included in:
Accounts receivable					1,8	21,9
Accounts payable					(13,5)	(10,2)
					(11,7)	11,7

The amounts reflected in the carrying value above consist of loans receivable and payable.

Amounts owing from the Ampath Trust have been pledged as security for certain loan financing obligations of the Ampath Trust Group.

Summarised balance sheet and income statement
The Group’s effective share of income statement and balance sheet items in respect of joint ventures is as follows:

	2006 Rm	2005 Rm
Income statements
Revenue	578,7	541,0
Operating profit	124,7	150,7
Financial income and expenses	(11,2)	(12,2)
Profit before taxation	113,5	138,5
Taxation	(9,8)	(5,3)
Profit after taxation	103,7	133,2
Balance sheets
Non-current assets	114,8	99,3
Current assets	136,2	115,6
Total assets	251,0	214,9
Equity	157,1	145,3
Non-current liabilities	23,5	12,2
Current liabilities	70,4	57,4
Total equity and liabilities	251,0	214,9